Impact of CYP1A1 Polymorphisms on Susceptibility to Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
Biomed Res Int
; 2015: 942958, 2015.
Article
em En
| MEDLINE
| ID: mdl-26425562
ABSTRACT
OBJECTIVE:
Several studies have evaluated the association between CYP1A1 polymorphisms and the susceptibility of chronic obstructive pulmonary disease (COPD) with inconclusive results. We performed the first comprehensive meta-analysis to summarize the association between CYP1A1 polymorphisms and COPD risk.METHOD:
A systematic literature search was conducted (up to April 2015) in five online databases PubMed, EMBASE, China National Knowledge Infrastructure (CNKI), WeiPu, and WanFang databases. The strength of association was calculated by odds ratio (OR) and corresponding 95% confidence interval (CI).RESULTS:
Seven case-control studies with 1050 cases and 1202 controls were included. Our study suggested a significant association between the MspI polymorphism and COPD risk (CC versus TC + TT OR = 1.57, CI 1.09-2.26, P = 0.02; CC versus TT OR = 1.73, CI 1.18-2.55, P = 0.005). For the Ile/Val polymorphism, a significant association with COPD risk was observed (GG versus AG + AA OR = 2.75, CI 1.29-5.84, P = 0.009; GG versus AA OR = 3.23, CI 1.50-6.93, P = 0.003; AG versus AA OR = 1.39, CI 1.01-1.90, P = 0.04). Subgroup analysis indicated a significant association between the MspI variation and COPD risk among Asians (CC versus TC + TT OR = 1.70, CI 1.06-2.71, P = 0.03; CC versus TT OR = 1.84, CI 1.11-3.06, P = 0.02).CONCLUSION:
The MspI and Ile/Val polymorphisms might alter the susceptibility of COPD, and MspI polymorphism might play a role in COPD risk among Asian population.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Polimorfismo Genético
/
Citocromo P-450 CYP1A1
/
Predisposição Genética para Doença
/
Doença Pulmonar Obstrutiva Crônica
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
/
Systematic_reviews
Limite:
Humans
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article